MedTrace Logo

Tart Cherries - The Influence on Acute Adaptation

NCT07354204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2026-01-21

No results posted yet for this study

Summary

The goal of this clinical trial is to compare recovery and impact on acute adaptation conferred by the RBE following eccentric exercise in healthy, active participants.

The main questions it aimed to answer were whether 7 day supplementation with Vistula tart cherries attenuated:

* muscle function
* inflammation
* soreness

Participants will either consume a spray-dried tart cherry supplement or a calorie-matched placebo-control for 7 days, and complete two bouts of eccentric exercise to the elbow flexors. Participants will perform functional tests, be assessed for their perceptual recovery and markers of inflammation and muscle damage via:

* maximal voluntary contractions
* visual analog scales to assess soreness
* blood samples

Conditions

  • Recovery

Interventions

DIETARY_SUPPLEMENT

Tart Cherry

7 day supplementation

OTHER

Placebo

7 day supplementation

Sponsors & Collaborators

  • Iprona Lana SpA

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Principal Investigators

  • Glyn Howatson · Northumbria Univeristy

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-11-01
Completion
2023-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07354204 on ClinicalTrials.gov